ABSTRACT A multi-treatment two stage adaptive allocation design is developed for survival responses. Assuming noninformative random censoring, asymptotic p values of relevant tests of equality of treatment effects are used… Click to show full abstract
ABSTRACT A multi-treatment two stage adaptive allocation design is developed for survival responses. Assuming noninformative random censoring, asymptotic p values of relevant tests of equality of treatment effects are used to derive the assignment probability of incoming second stage subjects. Several ethical and inferential criteria of the design are studied, and are compared with those of an existing competitor. Applicability and performance of the proposed design are also illustrated using a data arising from a real clinical trial.
               
Click one of the above tabs to view related content.